Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 63.71 | N/A |
| PEG Ratio (TTM) | -2.94 | N/A |
| P/S Ratio (TTM) | 0.68 | N/A |
| P/B Ratio (TTM) | 4.15 | N/A |
| P/FCF Ratio (TTM) | 100.64 | N/A |
| Price to 5YR AVG Earnings Ratio | 35.29 | N/A |
| Price to 5YR AVG FCF Ratio | 40.40 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.41% | N/A |
| ROE (TTM) | 6.05% | N/A |
| Net Profit Margin (TTM) | 1.08% | N/A |
| ROIC 5YR AVG | 18.43% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -4.75% | 39.55% | 25.34% |
| Revenue | -0.78% | 18.31% | 19.30% |
| Net Income | -5.11% | 40.61% | 25.81% |
| Cash Flow | 102.44% | 41.60% | 17.85% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.35 | N/A |
| Quick Ratio (TTM) | 1.35 | N/A |
| D/E Ratio (TTM) | 0.16 | N/A |
| Interest Coverage (TTM) | 9.24 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 4.38 | N/A |
| LTL to 5YR AVG FCF | 0.92 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.32% | N/A |